Nuve Revenue and Competitors
Estimated Revenue & Valuation
- Nuve's estimated annual revenue is currently $5.2M per year.
- Nuve's estimated revenue per employee is $116,000
Employee Data
- Nuve has 45 Employees.
- Nuve grew their employee count by 32% last year.
Nuve's People
Name | Title | Email/Phone |
---|---|---|
1 | Sales Engineer | Reveal Email/Phone |
Nuve Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.3M | 126 | 13% | N/A | N/A |
#2 | $94.1M | 519 | 24% | N/A | N/A |
#3 | $4.1M | 35 | 75% | N/A | N/A |
#4 | $310M | 1495 | 33% | $768M | N/A |
#5 | $406.7M | 2730 | 8% | $26.1M | N/A |
#6 | $15.4M | 106 | -61% | N/A | N/A |
#7 | $8.6M | 66 | 0% | N/A | N/A |
#8 | $13.9M | 96 | -5% | $752.5M | N/A |
#9 | $41.3M | 259 | 13% | N/A | N/A |
#10 | $58.7M | 324 | 23% | N/A | N/A |
What Is Nuve?
Nuve has developed a new technology based on sensors, a cloud-based platform and a mobile application that allows the asset management industry to better protect, control and monitor their property. IoT for the Asset Management indusrty. Austin · Sensors · Location Based Services · Analytics · Internet of Things
keywords:N/AN/A
Total Funding
45
Number of Employees
$5.2M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nuve News
2022-04-17 - Global Platelet Agitators Market Competitive Analysis ...
Nuve; Boekel Scientific; Newmeditech. Research offering well-studied comprehensions for Platelet Agitators Market. The verified secondary data...
2022-04-17 - Platelet Agitators Market: Increasing prevalence of chronic ...
Major players operating in the global platelet agitators market include Helmer Scientific, SARSTEDT AG & Co, Boekel Scientific, Nuve, Fanem,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9M | 45 | 22% | N/A |
#2 | $9.7M | 45 | 15% | N/A |
#3 | $5M | 45 | 7% | $29M |
#4 | $5.2M | 45 | N/A | N/A |
#5 | $9.7M | 45 | N/A | N/A |